Alina Vision Pte Ltd. announced that it has received in an equity round of funding on January 16, 2024. The transaction included participation from new investors, Fred Hollows Foundation, Rohto Pharmaceutical Co.,Ltd., and TVM Capital Healthcare Partners.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,083 JPY | +1.55% | +3.35% | +8.44% |
Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.44% | 4.42B | |
+26.47% | 664B | |
+26.11% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+12.77% | 234B | |
+5.01% | 199B | |
-9.82% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- Alina Vision Pte Ltd. announced that it has received funding from Fred Hollows Foundation, Rohto Pharmaceutical Co.,Ltd., TVM Capital Healthcare Partners